Secreted frizzled-related protein 2-mediated cancer events: Friend or foe?

Yanhui Liu1, Qun Zhou1, Dexi Zhou1

  • 1School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.

Insights

Secreted frizzled-related protein 2 (SFRP2) methylation impacts cancer progression. This review explores SFRP2

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • Secreted frizzled-related protein 2 (SFRP2) is frequently methylated in human cancers, leading to its down-regulation.
  • SFRP2's role in Wnt signaling pathway activity and tumor progression is complex, with evidence suggesting both anti-oncogenic and tumor-promoting functions.
  • Methylation of SFRP2 has been linked to accelerated cancer cell invasion and growth.

Purpose of the Study:

  • To review and synthesize current understanding of SFRP2's multifaceted roles in tumorigenesis.
  • To highlight the potential of SFRP2 as a therapeutic target for novel cancer treatments.

Main Methods:

  • Literature review of studies investigating SFRP2's function in various cancer types.
  • Analysis of research on SFRP2 methylation patterns and their correlation with cancer progression.
  • Evaluation of the Wnt signaling pathway's interaction with SFRP2 in cancer development.

Main Results:

  • SFRP2 exhibits dual roles in cancer, acting as an anti-oncogene in some contexts and a tumor promoter in others.
  • SFRP2 down-regulation via methylation is associated with enhanced cancer cell invasion, growth, and overall tumor progression.
  • Modulating Wnt signaling through SFRP2 presents a promising avenue for cancer therapy development.

Conclusions:

  • SFRP2's complex involvement in tumorigenesis necessitates further investigation.
  • Targeting SFRP2 offers potential for developing innovative anti-cancer drugs.
  • Understanding SFRP2's precise role in different cancer types is crucial for effective therapeutic strategies.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K